Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Health Serv.

Sec. Implementation Science

Volume 5 - 2025 | doi: 10.3389/frhs.2025.1566454

This article is part of the Research TopicDissemination and Implementation Science in MedicineView all 9 articles

Standard versus enhanced implementation strategies to increase adoption of a multidrug-resistant organism (MDRO) alert tool: A cluster randomized trial

Provisionally accepted
Cara  RayCara Ray1*Cassie  GoedkenCassie Goedken2Ashley  M. HughesAshley M. Hughes1,3Geneva  M. WilsonGeneva M. Wilson1,4Natalie  R. HicksNatalie R. Hicks5Margaret  A. FitzpatrickMargaret A. Fitzpatrick6,7Makoto  M. JonesMakoto M. Jones8Christopher  PfeifferChristopher Pfeiffer10,9James  Stacey KluttsJames Stacey Klutts11,12,13Martin  E. EvansMartin E. Evans5Katie  Joy SudaKatie Joy Suda14,15Charlesnika  EvansCharlesnika Evans1,4
  • 1Edward Hines Jr. VA Hospital, Center of Innovation for Complex Chronic Healthcare, Hines, IL, United States
  • 2Iowa City VA Medical Center, Center for Access and Delivery Research and Evaluation, United States Department of Veterans Affairs, Iowa City, Iowa, United States
  • 3Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
  • 4Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
  • 5VA National Infectious Diseases Service, MDRO Prevention Division, Washington, DC, United States
  • 6Rocky Mountain Regional VA Medical Center, Center of Innovation for Veteran Centered and Value Driven Care, Aurora, CO, United States
  • 7University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
  • 8VA Salt Lake City Health Care System, Informatics, Decision Enhancement, and Analytics Sciences Center, Salt Lake City, Utah, United States
  • 9VA Portland Healthcare System, Portland, OR, United States
  • 10Oregon Health and Science University, Portland, Oregon, United States
  • 11VA National Pathology and Laboratory Medicine Program Office, Washington, DC, United States
  • 12Iowa City VA Medical Center, Iowa City VA Health Care System, Veterans Health Administration, United States Department of Veterans Affairs, Iowa City, Iowa, United States
  • 13Carver College of Medicine, The University of Iowa, Iowa City, Iowa, United States
  • 14Center for Health Equity Research and Promotion, Pittsburgh, PA, United States
  • 15Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States

The final, formatted version of the article will be published soon.

BackgroundThe Veterans Health Administration (VHA) launched VA Bug Alert (VABA) to identify admitted patients who are infected or colonized with multidrug-resistant organisms (MDROs) in real time and promote timely infection prevention measures. However, initial VABA adoption was suboptimal. The objective of this project was to compare the effectiveness of standard versus enhanced implementation strategies for improving VABA adoption. Methods121 VA healthcare facilities were evaluated for adoption of VABA (at least 1 user registered at a facility) April 2021 – September 2022. All facilities initially received standard implementation, which included: VABA revisions based on end-user feedback, education, and internal facilitation via monthly meetings with the MDRO Prevention Division of the VHA National Infectious Diseases Service. Surveys evaluated VABA perspectives among MDRO Prevention Coordinators (MPCs) and/or Infection Preventionists (IPs) before and after initial standard implementation. Facilities not registered for VABA following initial standard implementation (n=31) were cluster-randomized to continue to receive standard implementation or enhanced implementation (audit and feedback reports and external facilitation via guided interviews to assess VABA use barriers). Percentages of facilities adopting VABA at baseline, after standard implementation (Follow-up 1), and after the enhanced vs. standard implementation trial period (Follow-up 2) were assessed and compared across time points using McNemar's test. VABA adoption was compared by trial condition using Fisher's exact test.ResultsBefore education, 25% of 167 MPC/IP survey respondents across 116 facilities reported no knowledge/use of VABA. After education, 82% of 92 survey respondents across 80 facilities reported intending to use VABA. At baseline, VABA registrations were 40%. Registrations significantly increased aft Follow-up 1(75%, p<0.01) and at Follow-up 2 (89%, p<0.01). Adoption did not significantly differ by assigned implementation condition but was higher among facilities that completed all components of enhanced implementation than those who did not (87.5% vs 43.5%, p=0.045). Guided interviews revealed key facilitators of VABA registration, which included perceived fit, implementation activities, and organizational context (e.g., staffing resources).ConclusionsImplementation efforts dramatically increased VABA registrations. Incorporating interview feedback to increase VABA's fit with users' needs may increase its use and help reduce MDRO spread in VA.

Keywords: Infection prevention, Implementation facilitation, user-centered design, Veterans Affairs, multidrug-resistant organism (MDRO)

Received: 24 Jan 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Ray, Goedken, Hughes, Wilson, Hicks, Fitzpatrick, Jones, Pfeiffer, Klutts, Evans, Suda and Evans. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Cara Ray, Edward Hines Jr. VA Hospital, Center of Innovation for Complex Chronic Healthcare, Hines, IL, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.